Isabelle Treilleux

Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer.

Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer.

Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis.

Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression.

Activation of rapid oestrogen signalling in aggressive human breast cancers.

Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells.

Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment.

Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network.

Combining chemotherapeutic agents and netrin-1 interference potentiates cancer cell death.

LKB1 when associated with methylatedERα is a marker of bad prognosis in breast cancer.

Management of patients diagnosed with atypical ductal hyperplasia by vacuum-assisted core biopsy: a prospective assessment of the guidelines used at our institution.

17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1.

Role of JMJD6 in Breast Tumourigenesis.

DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.

TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.

A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers.

Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4.

Non-canonical NOTCH3 signalling limits tumour angiogenesis.

Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRAS-driven Pancreatic Tumorigenesis.

Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer.

Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer.

Uncovering the Translational Regulatory Activity of the Tumor Suppressor BRCA1.

ERα-36 regulates progesterone receptor activity in breast cancer.

Clinical practice guidelines for BRCA1 and BRCA2 genetic testing.

Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant.

A Gender-Dependent Molecular Switch of Inflammation via MyD88/Estrogen Receptor-Alpha Interaction.

Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes.

Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial.

Frequency of Asbestos Exposure and Histological Subtype of Ovarian Carcinoma.

NF-κB-dependent secretome of senescent cells can trigger neuroendocrine transdifferentiation of breast cancer cells.

Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration.